Tumor-dependent Increased Plasma Nitrate Concentrations as an Indication of the Antitumor Effect of Flavone-8-acetic Acid and Analogues in Mice

Cancer Research

Volumn 51, Issue 1, 1991, Pages 77-81

  Baguley, Bruce C ^a,b   Ching, Lai Ming ^a   Zhuang, Li ^a  

^a Cancer Research Laboratory   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; MITOFLAXONE; MITOFLAXONE DERIVATIVE; NITRATE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENOCARCINOMA; ANIMAL; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONES; METHYLATION; MICE; MICE, INBRED STRAINS; NITRATES; NITRITES; SUPPORT, NON-U.S. GOV'T; XANTHENES;

EID: 0026089375     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Atassi, G., Briet, P., Berthelon. J-J., and Collonges, F. Synthesis and antitumour activity of some 8-substituted-4-oxo-4H-1-benzopyrans. Eur. J. Med. Chem., 5: 393-402, 1985.
2. Plowman. J., Naryanan, V. L., Dykes, D., et al. Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice. Cancer Treat. Rep., 70: 631-638, 1986.
3. Smith, G. P., Calveley. S. B., Smith, M. J., and Baguley. B. C. Flavone acetic acid (NSC 347512) induces haemorrhagic necrosis of mouse colon 26 and 38 tumours. Eur. J. Cancer Clin. Oncol., 23: 1209-1212, 1987.
4. Finlay. G. J., Smith. G. P., Fray, L. M., and Baguley, B. C. Effect of flavone acetic acid (NSC 347512) on Lewis lung carcinoma: evidence for an indirect effect. J. Natl. Cancer Inst., 80: 241-245, 1988.
5. Giavazzi, R., Garofalo, A., and Damia. G. Response to flavone acetic acid (NSC 347512) of primary and metastatic human colorectal carcinoma xenografts. Br. J. Cancer, 57: 277-280, 1988.
6. Kerr, D. J., Maughan, T., Newlands, E., et al. Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal cancer. Br. J. Cancer, 60: 104-106. 1989.
7. Evelhoch, J. L., Bissery. M.-C., Chabot, G. G., et al. Flavone acetic acid (NSC347512)-induced modulation of murine tumor physiology monitored by in vivo nuclear magnetic resonance spectroscopy. Cancer Res., 48: 4749-4755. 1988.
8. Bibby, M. C., Double, J. A., and Loadman. P. M. Reduction of tumor blood flow by flavone acetic acid: a possible component of therapy. J. Natl. Cancer Inst.,: 216-220, 1989.
9. Zwi, L. J., Baguley, B. C., Gavin, J. B., and Wilson, W. R. Blood flow failure as a major determinant in the antitumor action of flavone acetic acid (NSC 347512). J. Natl. Cancer Inst., 81: 1005-1013, 1989.
10. Mace, K. F., Hornung. R. L., Wiltrout, R. H., and Young, H. A. Induction of cytokine expression in vivo by flavone acetic acid: strict dose dependency and correlation with therapeutic efficacy against murine renal cancer. Cancer Res. 50: 1742-1747, 1990.
11. Ching, L-M., and Baguley. B. C. Induction of natural killer cell activity by the antitumour compound flavone acetic acid (NSC 347512). Eur. J. Cancer Clin. Oncol., 23: 1047-1050, 1987.
12. Hornung, R. L., Young, H. A., Urba, W. J., and Wiltrout, R. H. Immunomodulation of natural killer cell activity by flavone acetic acid: occurrence via induction of interferon a/fi. J. Natl. Cancer Inst., 80: 1226-1231. 1988.
13. Rewcastle, G. W., Atwell, G. J., Zhuang. L., Baguley, B. C., and Denny, W. A. Potential antitumor agents. 61. Structure-activity relationships for in vivo colon 38 activity among disubstituted 9-oxo-9/Y-xanthene-4-acetic acids. J. Med. Chem., in press. 1990.
14. Rewcastle, G. W., Atwell, G. J., Palmer, B. D., Boyd, P. D. W., Baguley, B. C., and Denny, W. A. Potential antitumor agents. 62. Structure-activity relationships for tricyclic compound related to the colon tumor active drug 9-oxoxanthene-4-acetic acid. J. Med. Chem., in press. 1990.
15. Ching, L-M., and Baguley. B. C. Enhancement of m vitro toxicity of mouse peritoneal exadate cells by flavone acetic acid (NSC 347512). Eur. J. Cancer Clin, Oncol., 24: 1514-1526, 1988.
16. Ching, L-M., and Baguley, B. C. Hyporesponsiveness of macrophages from C3H/HeJ (endotoxin-resistant) mice to the antitumour drug flavone acetic acid (NCS 347512). Eur. J. Cancer Clin. Oncol., 25: 1513-1515, 1989.
17. Thomsen. L. L., Ching, L-M., and Baguley. B. C. Evidence for the production of nitric oxide by activated macrophages treated with the antitumor agents flavone-8-acetic acid and xanthenone-4-acetic acid. Cancer Res., 50: 6966-6970, 1990.
18. Drapier. J-C, and Hibbs, J. B. Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondria! iron-sulfur enzymes in the macrophage effector cells. J. Immunol., 140: 2829-2838. 1988.
19. Hibbs, J. B., Taintor, R. R., Vavrin, Z., and Rachlin. E. M. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun., 757: 87-94. 1988.
20. Stuehr, D. J., and Marietta, M. A. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. USA. 42:7738-7742. 1985.
21. Leaf, C. D., Wishnok. J. S., Hurley. J. P., Rosenblad, W. D., Fox, J. G. and Tannenbaum, S. R. Nitrate biosynthesis in rats, ferrets, and humans. Precursor studies with L-arginine. Carcinogenesis (Lond.),//: 855-858. 1990.
22. Baguley. B. C., Calveley. S. B., Crowe, K. K., Fray, L. M., O'Rourke, S. A., and Smith. G. P. Comparison of the effects of flavone acetic acid, fostriecin. and homoharnngtonine and tumour necrosis factor a on colon 38 tumors in mice. Eur. J. Cancer Clin. Oncol., 25: 263-269. 1989.
23. Rewcastle, G. W., Kestell, P., Baguley. B. C., and Denny, W. A. Lightinduced breakdown of flavone acetic acid and xanthenone analogues in solution. J. Natl. Cancer Inst., 82: 528-529, 1990.
24. Davison, W., and Woof, C. Comparison of different forms of cadmium as reducing agents for the batch determination of nitrate. Analyst, 103: 403-406, 1978.
25. Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok. J. S., and Tannenbaum. S. R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem., 126: 131-138. 1982.
26. Griffith. T., and Randall. M. Nitric oxide comes of age. Lancet, 2: 875-876, 1989.
27. Marietta, M. A. Nitric oxide: biosynthesis and biological significance. Trends Biochem. Sci., 74:488-492, 1989.
28. Radomski, M. W., Palmer, R. M. J., and Moneada. S. An L-arginine nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. USA, 87: 5193-5197. 1990.
29. Drapier. J.-C., Wietzerbin, J., and Hibbs. J. B. Interferon-gamma and tumor necrosis factor induce the i -arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur. J. Immunol., 18: 1587-1592. 1988.
30. Stuehr, D. J., and Marietta, M. A. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines. or interferoné. J. Immunol., 139: 518-525. 1987.
31. Keller. R., Geiges. M., and Keist. R. L-Arginine-dependent reactive nitrogen intermediates as mediators of tumor cell killing by activated macrophages. Cancer Res., 50: 1421-1425, 1990.
32. Lancaster, J. R., and Hibbs. J. B. EPR demonstration of iron nitrosyl complex formation by cytotoxic activated macrophages. Proc. Natl. Acad. Sci. USA, 87: 1223-1227, 1990.
33. Beckman, J. S., Beckman. T. W., Chen, J., Marshall, P. A., and Freeman, B. A. Apparent hydroxylradical production by peroxynitrite: implications for endothelial injury from nitric oxide and Superoxide. Proc. Natl. Acad. Sci. USA. 87: 1620-1624, 1990.
34. Nathan. C. F. Secretory products of macrophages. J. Clin. Invest., 79: 319-326, 1987.
35. Higuchi, M., Higashi, N., Taki, H., and Osawa, T. Cytolytic mechanisms of activated macrophagesa-tumor necrosis factor and L-arginine-dependent mechanisms act synergistically as the major cytolytic mechanisms of activated macrophages. J. Immunol., 144: 1425-1431, 1990.